Replies to post #2992 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

RVNC fully-diluted shares @12/31/22=101.1M—a decrease of 0.1M since 9/30/22 (#msg-170437516):

• 82.4M basic shares on the 12/31/22 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001479290/000147929023000028/rvnc-20221231.htm#if71761b97b0747c7a288a1ec451595fd_262 );

• 4.9M options and 4.9M shares of unvested restricted stock and RSUs (ibid page F-40); and

• 8.9M shares deriving from the convertible debt issued in Feb 2020.

Note: No shares have been sold under the 2022 ATM facility.